Provided by Tiger Trade Technology Pte. Ltd.

Ascendis Pharma A/S

251.95
-1.3400-0.53%
Post-market: 251.950.00000.00%16:10 EDT
Volume:329.92K
Turnover:82.86M
Market Cap:16.68B
PE:19.28
High:256.35
Open:256.35
Low:247.03
Close:253.29
52wk High:282.15
52wk Low:186.05
Shares:66.19M
Float Shares:65.54M
Volume Ratio:0.66
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):13.07
EPS(LYR):-4.4176
ROE:118.78%
ROA:9.58%
PB:9.95
PE(LYR):-57.03

Loading ...

Ascendis Pharma price target raised to $345 from $342 at Barclays

TIPRANKS
·
May 11

Analysts Are Bullish on These Healthcare Stocks: Ascendis Pharma (ASND), Becton Dickinson (BDX)

TIPRANKS
·
May 11

Ascendis Pharma (ASND) Gets a Buy from RBC Capital

TIPRANKS
·
May 08

Earnings Flash (ASND) Ascendis Pharma Posts Q1 Non-IFRS EPS 0.27 Euro

MT Newswires Live
·
May 07

Ascendis Pharma Q1 Adj. EPS $0.32 Beats $0.21 Estimate, Sales $288.770M Miss $318.050M Estimate

Benzinga Earnings
·
May 07

Press Release: Ascendis Pharma Reports First Quarter 2026 Financial Results

Dow Jones
·
May 07

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 07

Ascendis Pharma posts ApproaCH trial Week 104 subgroup data presentation on achondroplasia

Reuters
·
May 07

Ascendis says TransCon CNP boosts growth velocity in achondroplasia children in 2-year trial data

Reuters
·
May 07

Ascendis Pharma A/S expected to post earnings of 20 cents a share - Earnings Preview

Reuters
·
May 05

Ascendis Pharma updates financial calendar with upcoming first-quarter results call

Reuters
·
May 01

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Apr 30

Assessing Ascendis Pharma (ASND) Valuation After Recent Share Price Uptick And Ongoing Losses

Simply Wall St.
·
Apr 27

Ascendis Pharma A/S expected to post earnings of 28 cents a share - Earnings Preview

Reuters
·
Apr 27

Ascendis Pharma to Redeem Senior Notes due 2028

MT Newswires Live
·
Apr 22

Ascendis Pharma calls USD 575 million convertible notes for redemption May 6

Reuters
·
Apr 22

European Equities Traded in the US as American Depositary Receipts Sharply Lower in Tuesday Trading

MT Newswires Live
·
Apr 21

Ascendis Pharma updates ISIN for Nasdaq Global Select Market-listed shares

Reuters
·
Apr 21

Ascendis Pharma ordinary shares begin trading on Nasdaq, replacing ADS listing

Reuters
·
Apr 20

Ascendis Pharma Is Maintained at Buy by B of A Securities

Dow Jones
·
Apr 16